The science behind transdermal delivery The skin acts as a highly effective barrier, designed to keep harmful substances out and essential fluids in
The practical implications are significant
Scientific and institutional sources All figures and dates cited in this comparison are based on published clinical trials and the following official opinions, verified on May 8, 2026
Subsequent work expanded its functional repertoire to include modulation of anxiety-like behavior, food intake, and metabolic homeostasis
But heres what the headlines often miss: your body produces GLP-1 on its own, every time you eat and certain foods can significantly increase how much you produce and how long it stays active

Key timing considerations: Side effect profile tends to be somewhat milder than semaglutide, which may reduce the importance of sleep-through timing Same 48-hour minimum spacing rule applies if changing injection days Pre-filled pen format means no reconstitution time, making spontaneous timing adjustments easier Many dulaglutide users report minimal side effects after the first month, at which point timing becomes purely a convenience decision Retatrutide (weekly injectable, investigational) Dosing frequency: Once weekly Half-life: Data from Phase 2 trials suggest approximately 6 days Peak concentration: Approximately 24 to 72 hours after injection Recommended timing approach: As a triple agonist (GLP-1/GIP/glucagon), retatrutide may produce a different side effect profile than pure GLP-1 or dual GLP-1/GIP agonists